FDA Issues EUA to Baricitinib Plus Remdesivir for COVID-19
Emergency use authorization applies to hospitalized patients requiring supplemental oxygen, mechanical ventilation, ECMO
Emergency use authorization applies to hospitalized patients requiring supplemental oxygen, mechanical ventilation, ECMO